Publications

Identification of p38 MAPK inhibition as a neuroprotective strategy for combinatorial SMA therapy

 65
Identification of p38 MAPK inhibition as a neuroprotective strategy for combinatorial SMA therapy

Tags:

Previous Article

ERK1/2 signaling targeting in cancer

Next Article

MAPK inhibition to protect against spinal muscular atrophy

Related Posts

Microbiome: a driver of pancreatic inflammation and tumorigenesis

Microbiome: a driver of pancreatic inflammation and tum...

 33

Human pancreatic α-cell heterogeneity and trajectory inference analyses reveal SMOC1 as a β-cell dedifferentiation gene

Human pancreatic α-cell heterogeneity and trajectory in...

 98

Aspartate signalling drives lung metastasis via alternative translation

Aspartate signalling drives lung metastasis via alterna...

 100